Natural history of β-cell adaptation and failure in type 2 diabetes

Emilyn U. Alejandro, Brigid Gregg, Manuel Blandino Rosano, Corentin Cras-Méneur, Ernesto Bernal Mizrachi

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Type 2 diabetes mellitus (T2D) is a complex disease characterized by β-cell failure in the setting of insulin resistance. The current evidence suggests that genetic predisposition, and environmental factors can impair the capacity of the β-cells to respond to insulin resistance and ultimately lead to their failure. However, genetic studies have demonstrated that known variants account for less than 10% of the overall estimated T2D risk, suggesting that additional unidentified factors contribute to susceptibility of this disease. In this review, we will discuss the different stages that contribute to the development of β-cell failure in T2D. We divide the natural history of this process in three major stages: susceptibility, β-cell adaptation and β-cell failure, and provide an overview of the molecular mechanisms involved. Further research into mechanisms will reveal key modulators of β-cell failure and thus identify possible novel therapeutic targets and potential interventions to protect against β-cell failure.

Original languageEnglish (US)
Pages (from-to)19-41
Number of pages23
JournalMolecular Aspects of Medicine
Volume42
DOIs
StatePublished - Apr 1 2015
Externally publishedYes

Fingerprint

Medical problems
Natural History
Type 2 Diabetes Mellitus
Insulin
Modulators
Insulin Resistance
Disease Susceptibility
Genetic Predisposition to Disease
Research

Keywords

  • Glucolipotoxicity
  • Insulin resistance
  • Islet biology
  • β-cell development
  • β-cell failure
  • β-cell programming

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Clinical Biochemistry
  • Medicine(all)

Cite this

Natural history of β-cell adaptation and failure in type 2 diabetes. / Alejandro, Emilyn U.; Gregg, Brigid; Blandino Rosano, Manuel; Cras-Méneur, Corentin; Bernal Mizrachi, Ernesto.

In: Molecular Aspects of Medicine, Vol. 42, 01.04.2015, p. 19-41.

Research output: Contribution to journalArticle

@article{fa12ea1717f54aa3a99ac9720cc17efb,
title = "Natural history of β-cell adaptation and failure in type 2 diabetes",
abstract = "Type 2 diabetes mellitus (T2D) is a complex disease characterized by β-cell failure in the setting of insulin resistance. The current evidence suggests that genetic predisposition, and environmental factors can impair the capacity of the β-cells to respond to insulin resistance and ultimately lead to their failure. However, genetic studies have demonstrated that known variants account for less than 10{\%} of the overall estimated T2D risk, suggesting that additional unidentified factors contribute to susceptibility of this disease. In this review, we will discuss the different stages that contribute to the development of β-cell failure in T2D. We divide the natural history of this process in three major stages: susceptibility, β-cell adaptation and β-cell failure, and provide an overview of the molecular mechanisms involved. Further research into mechanisms will reveal key modulators of β-cell failure and thus identify possible novel therapeutic targets and potential interventions to protect against β-cell failure.",
keywords = "Glucolipotoxicity, Insulin resistance, Islet biology, β-cell development, β-cell failure, β-cell programming",
author = "Alejandro, {Emilyn U.} and Brigid Gregg and {Blandino Rosano}, Manuel and Corentin Cras-M{\'e}neur and {Bernal Mizrachi}, Ernesto",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.mam.2014.12.002",
language = "English (US)",
volume = "42",
pages = "19--41",
journal = "Molecular Aspects of Medicine",
issn = "0098-2997",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Natural history of β-cell adaptation and failure in type 2 diabetes

AU - Alejandro, Emilyn U.

AU - Gregg, Brigid

AU - Blandino Rosano, Manuel

AU - Cras-Méneur, Corentin

AU - Bernal Mizrachi, Ernesto

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Type 2 diabetes mellitus (T2D) is a complex disease characterized by β-cell failure in the setting of insulin resistance. The current evidence suggests that genetic predisposition, and environmental factors can impair the capacity of the β-cells to respond to insulin resistance and ultimately lead to their failure. However, genetic studies have demonstrated that known variants account for less than 10% of the overall estimated T2D risk, suggesting that additional unidentified factors contribute to susceptibility of this disease. In this review, we will discuss the different stages that contribute to the development of β-cell failure in T2D. We divide the natural history of this process in three major stages: susceptibility, β-cell adaptation and β-cell failure, and provide an overview of the molecular mechanisms involved. Further research into mechanisms will reveal key modulators of β-cell failure and thus identify possible novel therapeutic targets and potential interventions to protect against β-cell failure.

AB - Type 2 diabetes mellitus (T2D) is a complex disease characterized by β-cell failure in the setting of insulin resistance. The current evidence suggests that genetic predisposition, and environmental factors can impair the capacity of the β-cells to respond to insulin resistance and ultimately lead to their failure. However, genetic studies have demonstrated that known variants account for less than 10% of the overall estimated T2D risk, suggesting that additional unidentified factors contribute to susceptibility of this disease. In this review, we will discuss the different stages that contribute to the development of β-cell failure in T2D. We divide the natural history of this process in three major stages: susceptibility, β-cell adaptation and β-cell failure, and provide an overview of the molecular mechanisms involved. Further research into mechanisms will reveal key modulators of β-cell failure and thus identify possible novel therapeutic targets and potential interventions to protect against β-cell failure.

KW - Glucolipotoxicity

KW - Insulin resistance

KW - Islet biology

KW - β-cell development

KW - β-cell failure

KW - β-cell programming

UR - http://www.scopus.com/inward/record.url?scp=84937071614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937071614&partnerID=8YFLogxK

U2 - 10.1016/j.mam.2014.12.002

DO - 10.1016/j.mam.2014.12.002

M3 - Article

VL - 42

SP - 19

EP - 41

JO - Molecular Aspects of Medicine

JF - Molecular Aspects of Medicine

SN - 0098-2997

ER -